244 related articles for article (PubMed ID: 20795735)
1. Validation of in vitro cell-based human blood-brain barrier model using clinical positron emission tomography radioligands to predict in vivo human brain penetration.
Mabondzo A; Bottlaender M; Guyot AC; Tsaouin K; Deverre JR; Balimane PV
Mol Pharm; 2010 Oct; 7(5):1805-15. PubMed ID: 20795735
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.
Josserand V; Pélerin H; de Bruin B; Jego B; Kuhnast B; Hinnen F; Ducongé F; Boisgard R; Beuvon F; Chassoux F; Daumas-Duport C; Ezan E; Dollé F; Mabondzo A; Tavitian B
J Pharmacol Exp Ther; 2006 Jan; 316(1):79-86. PubMed ID: 16210395
[TBL] [Abstract][Full Text] [Related]
3. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
4. Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model.
Roux GL; Jarray R; Guyot AC; Pavoni S; Costa N; Théodoro F; Nassor F; Pruvost A; Tournier N; Kiyan Y; Langer O; Yates F; Deslys JP; Mabondzo A
Sci Rep; 2019 Nov; 9(1):16310. PubMed ID: 31690750
[TBL] [Abstract][Full Text] [Related]
5. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
[TBL] [Abstract][Full Text] [Related]
6. Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models.
Lundquist S; Renftel M; Brillault J; Fenart L; Cecchelli R; Dehouck MP
Pharm Res; 2002 Jul; 19(7):976-81. PubMed ID: 12180550
[TBL] [Abstract][Full Text] [Related]
7. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.
Megard I; Garrigues A; Orlowski S; Jorajuria S; Clayette P; Ezan E; Mabondzo A
Brain Res; 2002 Feb; 927(2):153-67. PubMed ID: 11821009
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G
Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236
[TBL] [Abstract][Full Text] [Related]
9. Efficiency gains in tracer identification for nuclear imaging: can in vivo LC-MS/MS evaluation of small molecules screen for successful PET tracers?
Joshi EM; Need A; Schaus J; Chen Z; Benesh D; Mitch C; Morton S; Raub TJ; Phebus L; Barth V
ACS Chem Neurosci; 2014 Dec; 5(12):1154-63. PubMed ID: 25247893
[TBL] [Abstract][Full Text] [Related]
10. Establishment of a new conditionally immortalized cell line from human brain microvascular endothelial cells: a promising tool for human blood-brain barrier studies.
Kamiichi A; Furihata T; Kishida S; Ohta Y; Saito K; Kawamatsu S; Chiba K
Brain Res; 2012 Dec; 1488():113-22. PubMed ID: 23041702
[TBL] [Abstract][Full Text] [Related]
11. Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging.
Sadeghzadeh M; Wenzel B; Gündel D; Deuther-Conrad W; Toussaint M; Moldovan RP; Fischer S; Ludwig FA; Teodoro R; Jonnalagadda S; Jonnalagadda SK; Schüürmann G; Mereddy VR; Drewes LR; Brust P
Molecules; 2020 May; 25(10):. PubMed ID: 32423056
[TBL] [Abstract][Full Text] [Related]
12. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
13. Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development.
Ohtsuki S; Terasaki T
Pharm Res; 2007 Sep; 24(9):1745-58. PubMed ID: 17619998
[TBL] [Abstract][Full Text] [Related]
14. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
15. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery.
Lacombe O; Videau O; Chevillon D; Guyot AC; Contreras C; Blondel S; Nicolas L; Ghettas A; Bénech H; Thevenot E; Pruvost A; Bolze S; Krzaczkowski L; Prévost C; Mabondzo A
Mol Pharm; 2011 Jun; 8(3):651-63. PubMed ID: 21438632
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
[TBL] [Abstract][Full Text] [Related]
17. [Imaging blood-brain barrier function by using positron emission tomography to evaluate drug penetration into the brain].
Takano H; Suhara T
Brain Nerve; 2013 Feb; 65(2):137-43. PubMed ID: 23399671
[TBL] [Abstract][Full Text] [Related]
18. Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays.
Lohmann C; Hüwel S; Galla HJ
J Drug Target; 2002 Jun; 10(4):263-76. PubMed ID: 12164375
[TBL] [Abstract][Full Text] [Related]
19. In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation.
Zhang X; Liu T; Fan X; Ai N
J Mol Graph Model; 2017 Aug; 75():347-354. PubMed ID: 28628860
[TBL] [Abstract][Full Text] [Related]
20. Caco-2 permeability, P-glycoprotein transport ratios and brain penetration of heterocyclic drugs.
Faassen F; Vogel G; Spanings H; Vromans H
Int J Pharm; 2003 Sep; 263(1-2):113-22. PubMed ID: 12954186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
